KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Depreciation & Amortization (CF) (2016 - 2026)

Opko Health filings provide 17 years of Depreciation & Amortization (CF) readings, the most recent being $22.2 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 5.48% to $22.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $90.3 million, a 25.81% increase, with the full-year FY2025 number at $91.6 million, down 6.67% from a year prior.
  • Depreciation & Amortization (CF) hit $22.2 million in Q1 2026 for Opko Health, down from $22.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $28.0 million in Q2 2022 to a low of $22.2 million in Q1 2026.
  • Median Depreciation & Amortization (CF) over the past 5 years was $25.9 million (2023), compared with a mean of $25.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 47.63% in 2022 and later decreased 9.04% in 2025.
  • Opko Health's Depreciation & Amortization (CF) stood at $26.5 million in 2022, then decreased by 1.81% to $26.0 million in 2023, then decreased by 7.0% to $24.2 million in 2024, then fell by 7.41% to $22.4 million in 2025, then dropped by 0.77% to $22.2 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $22.2 million (Q1 2026), $22.4 million (Q4 2025), and $22.7 million (Q3 2025) per Business Quant data.